(Q51640527)

8 April 2018

title

Effects on energy utilization of a beta3-adrenergic agonist in rats fed on a cafeteria diet. (English)

1 reference

8 April 2018

author name string

B Berraondo

1

1 reference

8 April 2018

A Bonafonte

2

1 reference

8 April 2018

M P Fernandez-Otero

3

1 reference

8 April 2018

J A Martinez

4

1 reference

8 April 2018

publication date

1 September 1997

1 reference

8 April 2018

Eating and Weight Disorders

published in

1 reference

8 April 2018

volume

2

1 reference

8 April 2018

issue

3

1 reference

8 April 2018

page(s)

130-137

1 reference

8 April 2018

cites work

Current views on obesity

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Physiological and metabolic consequences of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Beta-agonists as antiobesity, antidiabetic and nutrient partitioning agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

ICI D7114 a novel selective β-adrenoceptor agonist selectively stimulates brown fat and increases whole-body oxygen consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Function and regulation of the beta 3-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Potential anti-diabetic applications of a new molecule with affinity for beta 3-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Direct evidence for the atypical nature of functional beta-adrenoceptors in rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Molecular characterization of the human beta 3-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Antiobesity and antidiabetic beta-agonists: lessons learned and questions to be answered

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Persistent obesity in rats following a period of consumption of a mixed, high energy diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

The weight gain and ultimate adiposity in cafeteria diet-induced obesity is unrelated to the central serotoninergic tonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Polymorphism of the beta3-adrenergic receptor gene affects basal metabolic rate in obese Finns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03339963

Role of fragment peptides from ob protein on body weight and thermogenesis control: a screening.

21 January 2018

1 reference

12 December 2020

Effect of the beta-adrenoceptor agonist BRL-35135 on development of obesity in suckling Zucker (fa/fa) rats

1 reference

12 December 2020

Phenethanolamine derivatives with calorigenic and antidiabetic qualities

1 reference

12 December 2020

Thermogenesis and weight control

1 reference

12 December 2020

Effects on metabolic rate and fuel selection of a selective beta-3 agonist (ICI D7114) in healthy lean men

1 reference

12 December 2020

Pharmacology of thermogenic drugs

1 reference

12 December 2020

ICI D7114: a novel selective adrenoceptor agonist of brown fat and thermogenesis

1 reference

12 December 2020

The impact of obesity on health status: some implications for health care costs

1 reference

12 December 2020

Improvement of metabolic disorders and visceral fat obesity by the beta 3-adrenoceptor agonist (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2 -(3-chlorophenyl)ethylamino]propyl]-phenoxyacetate hydrobromide (BRL35135A) in genetically obese rodents

1 reference

12 December 2020

Pathophysiology of obesity

1 reference

12 December 2020

Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats

1 reference

12 December 2020

Long-term intervention strategies in obesity treatment

1 reference

12 December 2020

Anti-obesity and anti-diabetic effects of CL 316,243, a highly specific beta 3-adrenoceptor agonist, in yellow KK mice

1 reference

12 December 2020

BRL 35135, a potent and selective atypical beta-adrenoceptor agonist

1 reference

12 December 2020

Energy balance and mitochondrial function in liver and brown fat of rats fed "cafeteria" diets of varying protein content

1 reference

12 December 2020

Effects of trecadrine, a beta 3-adrenergic agonist, on intestinal absorption of D-galactose and disaccharidase activities in three physiopathological models

1 reference

12 December 2020

Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes

1 reference

12 December 2020

[Specific stimulation of adipose tissue adrenergic beta 3 receptors by octopamine]

1 reference

12 December 2020

Determination of Body Composition in Growing Rats by Total Body Electrical Conductivity

1 reference

12 December 2020

An adipose tissue-specific beta-adrenergic receptor. Molecular cloning and down-regulation in obesity

1 reference

12 December 2020

Prospects for beta 3-adrenoceptor agonists in the treatment of obesity and diabetes

1 reference

12 December 2020

Anti-Obesity and Anti-Diabetic Actions of a .BETA.3-Adrenoceptor Agonist, BRL 26830A, in Yellow KK Mice

1 reference

12 December 2020

Molecular cloning and expression of the rat beta 3-adrenergic receptor

1 reference

12 December 2020

Desensitization effect of in vivo treatment with metaproterenol on β1, β2 and β3-adrenergic responsiveness in rat adipocytes

1 reference

12 December 2020

Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis

1 reference

12 December 2020

In vivo increase in beta-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet

1 reference

12 December 2020

Substrate supply for thermogenesis induced by the beta-adrenoceptor agonist BRL 26830A

1 reference

12 December 2020

The antiobesity and metabolic activities of LY79771 in obese and normal mice

1 reference

12 December 2020

Changes in serum and urinary amino acids after the administration of a mixed beta-adrenergic agonist

1 reference

12 December 2020

Improved glycemic control in C57Bl/KsJ (db/db) mice after treatment with the thermogenic beta-adrenoceptor agonist, BRL 26830

1 reference

12 December 2020

The effects of a new beta-adrenoceptor agonist BRL 26830A in refractory obesity

1 reference

12 December 2020

Muscles of diabetic (db/db) mice: fibre size, fibre type and the effects of a thermogenic, beta-adrenoceptor agonist

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03339963

1 reference

8 April 2018

1 reference

8 April 2018